Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to 0.47.

  • Amphastar Pharmaceuticals' Equity Ratio fell 101.13% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 101.13%. This contributed to the annual value of 0.46 for FY2024, which is 983.82% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Equity Ratio stood at 0.47 for Q3 2025, which was down 101.13% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Equity Ratio ranged from a high of 0.71 in Q4 2022 and a low of 0.39 during Q3 2023
  • Its 5-year average for Equity Ratio is 0.56, with a median of 0.48 in 2024.
  • In the last 5 years, Amphastar Pharmaceuticals' Equity Ratio crashed by 4457.41% in 2023 and then surged by 2222.69% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Equity Ratio (Quarter) stood at 0.66 in 2021, then increased by 7.39% to 0.71 in 2022, then plummeted by 40.68% to 0.42 in 2023, then rose by 9.84% to 0.46 in 2024, then increased by 0.42% to 0.47 in 2025.
  • Its last three reported values are 0.47 in Q3 2025, 0.47 for Q2 2025, and 0.46 during Q1 2025.